GVR Report cover Needle-free Injectors Market Size, Share & Trends Report

Needle-free Injectors Market Size, Share & Trends Analysis Report By Product (Fillable, Prefilled), By Technology, By Type, By Application, By Usability, By Delivery Site, By End-use, By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453367
  • Number of Pages: 0
  • Format: Electronic (PDF)

An increasing number of infectious diseases across the globe is escalating the demand for self-injection devices, and the rising need for vaccination is the major factor projected to fuel the market growth. An increase in the geriatric population base developing communicable diseases due to needle stick injuries is estimated to surge the demand for needle-free Injectors over the forecast period. Additionally, the rising focus of market players on developing safe, pain-free, and advanced injectors is expected to augment the market expansion.

Recent advancements and product approvals as well as upgradation in needle-free injectors are anticipated to contribute towards market growth. In August 2022, WHO nominated the PharmaJet Tropis needle-free Injection System for huge polio vaccination campaigns. In July 2022, NuGen Medical Devices Inc. announced that its InsuJet has been approved and accepted by Health Canada explicitly for the needle-free delivery of insulin.

Needle-free Injectors Market Segmentation



By Product

  • Fillable
  • Prefilled

By Technology

  • Spring-based needle-free Injectors
  • Gas-powered needle-free Injectors
  • Laser-powered needle-free Injectors
  • Vibration-based needle-free Injectors

By Type

  • Powder-based needle-free Injectors
  • Liquid-based needle-free Injectors
  • Projectile/depot-based needle-free Injectors

By Application

  • Vaccine Delivery
  • Insulin Delivery
  • Pain Management
  • Others

By Usability

  • Reusable
  • Disposable

By Delivery Site

  • Subcutaneous
  • Intramuscular
  • Intradermal

By End-use

  • Hospitals & Clinics
  • Home Care Settings
  • Research Laboratories

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


Injections are one of the most common medical devices used for drug administration. Due to this, healthcare professionals are at great risk of exposure to bloodborne pathogens owing to needle stick injuries, which can occur accidentally. According to Occupational Safety and Health Administration (OSHA), around 590,000 needle stick accidents occur each year.

Asia Pacific region is estimated to exhibit the highest CAGR during the forecast period owing to increasing investments in the region by key market players, and rapid development of the healthcare industry in countries such as India, China, Japan, and others. Availability of low-cost labor for manufacturing, growing demand for self-injection devices, and the presence of favorable regulatory scenarios are major factors anticipated to create wide growth opportunities for current and upcoming market players.

Some of the major companies operating in the needle-free Injectors market are PharmaJet, Crossject, Portal Instruments, NuGen Medical Devices, Inovio Pharmaceuticals, Antares Pharma, Inc, Aijex Pharma International Inc., Ferring B.V., Penjet Corporation, and Medical International Technology Inc. These market players are focusing on developing several organic and inorganic growth strategies such as mergers & acquisitions, collaboration, product launch, and partnerships, to diversify and expand their market presence.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.